Home > Insider Trading > Filing (0001214659-19-008005)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1576263	Mirati Therapeutics Inc.	MRTX	Pharmaceutical Preparations (2834)	462693615

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1599324	Jamie Christensen	C/O Mirati Therapeutics, Inc. 9393 Towne Centre Drive, Ste 200 San Diego CA 92121	Evp, Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-12-23	2,499	$5.50	11,658	No	4	M	Direct
Common Stock	Disposition	2019-12-23	2,499	$125.00	9,159	No	4	S	Direct
Common Stock	Acquisiton	2019-12-23	4,167	$5.40	13,326	No	4	M	Direct
Common Stock	Disposition	2019-12-23	4,167	$125.00	9,159	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2019-12-23	2,499	$0.00	2,499	$5.50
Common Stock	Employee Stock Option (Right to Buy)	Disposition	2019-12-23	4,167	$0.00	4,167	$5.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,003		2026-10-26	No	4	M	Direct
28,125		2027-01-25	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 20, 2018.
Includes 256 shares acquired under the ESPP Purchase on 05/31/2019 and 114 shares acquired under the ESPP purchase on 11/29/2019.
1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.